Signaling Pathway
Cifurtilimab (SEA-CD40) is an agonistic, non-fucosylated human IgG1 monoclonal antibody that targets CD40, a co-stimulatory protein found on antigen-presenting cells. This antibody has been engineered to enhance immune activation and exhibits significant antitumor activities, making it a valuable tool for research in cancer immunotherapy.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Cifurtilimab (SEA-CD40) is an agonistic, non-fucosylated human IgG1 monoclonal antibody that targets CD40, a co-stimulatory protein found on antigen-presenting cells. This antibody has been engineered to enhance immune activation and exhibits significant antitumor activities, making it a valuable tool for research in cancer immunotherapy. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
